Literature DB >> 25196542

Immunoglobulin (Ig)G purified from human sera mirrors intravenous Ig human leucocyte antigen (HLA) reactivity and recognizes one's own HLA types, but may be masked by Fab complementarity-determining region peptide in the native sera.

M H Ravindranath1, P I Terasaki, C Y Maehara, V Jucaud, S Kawakita, T Pham, W Yamashita.   

Abstract

Intravenous immunoglobulin (IVIg) reacted with a wide array of human leucocyte antigen (HLA) alleles, in contrast to normal sera, due possibly to the purification of IgG from the pooled plasma. The reactivity of IgG purified from normal sera was compared with that of native sera to determine whether any serum factors mask the HLA reactivity of anti-HLA IgG and whether IgG purified from sera can recognize the HLA types of the corresponding donors. The purified IgG, unlike native sera, mirrored IVIg reactivity to a wide array of HLA-I/-II alleles, indicating that anti-HLA IgG may be masked in normal sera - either by peptides derived from soluble HLA or by those from antibodies. A < 3 kDa peptide from the complementarity-determining region (CDR) of the Fab region of IgG (but not the HLA peptides) masked HLA recognition by the purified IgG. Most importantly, some of the anti-HLA IgG purified from normal sera - and serum IgG from a few donors - indeed recognized the HLA types of the corresponding donors, confirming the presence of auto-HLA antibodies. Comparison of HLA types with the profile of HLA antibodies showed auto-HLA IgG to the donors' HLA antigens in this order of frequency: DPA (80%), DQA (71%), DRB345 (67%), DQB (57%), Cw (50%), DBP (43%), DRB1 (21%), A (14%) and B (7%). The auto-HLA antibodies, when unmasked in vivo, may perform immunoregulatory functions similar to those of therapeutic preparations of IVIg.
© 2014 British Society for Immunology.

Entities:  

Keywords:  CDR peptide; HLA autoantibody; HLA reactivity; HLA typing; intravenous immunoglobulin

Mesh:

Substances:

Year:  2015        PMID: 25196542      PMCID: PMC4298408          DOI: 10.1111/cei.12450

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  38 in total

Review 1.  A threshold model for the susceptibility to transfusion-related acute lung injury.

Authors:  U J Sachs
Journal:  Transfus Clin Biol       Date:  2012-06-05       Impact factor: 1.406

Review 2.  Towards a unified theory of immunoglobulin structure-function relations.

Authors:  T Kieber-Emmons; H Kohler
Journal:  Immunol Rev       Date:  1986-04       Impact factor: 12.988

3.  Transfusion-related acute lung injury after the infusion of IVIG.

Authors:  A Rizk; K C Gorson; L Kenney; R Weinstein
Journal:  Transfusion       Date:  2001-02       Impact factor: 3.157

4.  Susceptibility of lung transplants to preformed donor-specific HLA antibodies as detected by flow cytometry.

Authors:  J C Scornik; D S Zander; M A Baz; W H Donnelly; E D Staples
Journal:  Transplantation       Date:  1999-11-27       Impact factor: 4.939

5.  Levels of anti-albumin autoantibodies in acute and chronic hepatitis B virus infection.

Authors:  S Nardiello; T Pizzella; C Ronga; B Galanti
Journal:  Hepatogastroenterology       Date:  1990-12

6.  Natural mouse and human antibodies bind to a peptide derived from a germline VH chain. Evidence for evolutionary conserved self-binding locus.

Authors:  S V Kaveri; C Y Kang; H Köhler
Journal:  J Immunol       Date:  1990-12-15       Impact factor: 5.422

7.  Plasmapheresis and intravenous immune globulin provides effective rescue therapy for refractory humoral rejection and allows kidneys to be successfully transplanted into cross-match-positive recipients.

Authors:  R A Montgomery; A A Zachary; L C Racusen; M S Leffell; K E King; J Burdick; W R Maley; L E Ratner
Journal:  Transplantation       Date:  2000-09-27       Impact factor: 4.939

Review 8.  Use of high-dose human intravenous immunoglobulin therapy in sensitized patients awaiting transplantation: the Cedars-Sinai experience.

Authors:  Stanley C Jordan; Ashley A Vo; Cynthia C Nast; Dolly Tyan
Journal:  Clin Transpl       Date:  2003

9.  TRALI: correlation of antigen-antibody and monocyte activation in donor-recipient pairs.

Authors:  Patricia M Kopko; Teresa G Paglieroni; Mark A Popovsky; Kathryn N Muto; Malcolm R MacKenzie; Paul V Holland
Journal:  Transfusion       Date:  2003-02       Impact factor: 3.157

10.  Idiotypic self binding of a dominant germline idiotype (T15). Autobody activity is affected by antibody valency.

Authors:  C Y Kang; H L Cheng; S Rudikoff; H Kohler
Journal:  J Exp Med       Date:  1987-05-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Mechanisms of action of Ig preparations: immunomodulatory and anti-inflammatory effects.

Authors:  Andrea Matucci; Enrico Maggi; Alessandra Vultaggio
Journal:  Front Immunol       Date:  2015-01-12       Impact factor: 7.561

Review 2.  HLA Class Ia and Ib Polyreactive Anti-HLA-E IgG2a Monoclonal Antibodies (TFL-006 and TFL-007) Suppress Anti-HLA IgG Production by CD19+ B Cells and Proliferation of CD4+ T Cells While Upregulating Tregs.

Authors:  Mepur H Ravindranath
Journal:  J Immunol Res       Date:  2017-05-28       Impact factor: 4.818

3.  Detection of Antibodies Against Human Leukocyte Antigen Class II in the Sera of Patients Receiving Intravenous Immunoglobulin.

Authors:  Hiroyuki Takamatsu; Shinya Yamada; Noriaki Tsuji; Noriharu Nakagawa; Erika Matsuura; Atsuo Kasada; Keijiro Sato; Kohei Hosokawa; Noriko Iwaki; Masahisa Arahata; Hidenori Tanaka; Shinji Nakao
Journal:  Transplant Direct       Date:  2021-05-18

4.  Alloimmunity to Class 2 Human Leucocyte Antigens May Reduce HIV-1 Acquisition - A Nested Case-Control Study in HIV-1 Serodiscordant Couples.

Authors:  Melinda S Suchard; Neil Martinson; Susan Malfeld; Debbie de Assis Rosa; Romel D Mackelprang; Jairam Lingappa; Xuanlin Hou; Helen Rees; Sinead Delany-Moretlwe; Hadassa Goldfein; Heena Ranchod; David Coetzee; Kennedy Otwombe; Lynn Morris; Caroline T Tiemessen; Dana M Savulescu
Journal:  Front Immunol       Date:  2022-03-24       Impact factor: 7.561

5.  A Comprehensive Evaluation of the Antibody-Verified Status of Eplets Listed in the HLA Epitope Registry.

Authors:  Suzanne Bezstarosti; Kim H Bakker; Cynthia S M Kramer; Johan W de Fijter; Marlies E J Reinders; Arend Mulder; Frans H J Claas; Sebastiaan Heidt
Journal:  Front Immunol       Date:  2022-01-28       Impact factor: 7.561

Review 6.  Role of HLA-I Structural Variants and the Polyreactive Antibodies They Generate in Immune Homeostasis.

Authors:  Mepur H Ravindranath; Fatiha El Hilali; Carly J Amato-Menker; Hajar El Hilali; Senthamil R Selvan; Edward J Filippone
Journal:  Antibodies (Basel)       Date:  2022-09-08

Review 7.  The Homophilic Domain - An Immunological Archetype.

Authors:  Heinz Kohler; Jagadeesh Bayry; Srinivas V Kaveri
Journal:  Front Immunol       Date:  2016-03-21       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.